Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 112, Issue 9, Pages 1419-1428Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI200319028
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL053325, R01 HL061001, R37 HL053325, HL-53325, R01 HL062295, HL-62295, HL-61001] Funding Source: Medline
- NIGMS NIH HHS [GM-55849, R01 GM055849] Funding Source: Medline
Ask authors/readers for more resources
Supravalvular aortic stenosis is an autosomal-dominant disease of elastin (Eln) insufficiency caused by loss-of-function mutations or gene deletion. Recently, we have modeled this disease in mice (Eln(+/-)) and found that Eln haploinsufficiency results in unexpected changes in cardiovascular hemodynamics and arterial wall structure. Eln(+/-) animals were found to be stably hypertensive from birth, with a mean arterial pressure 25-30 mmHg higher than their wild-type counterparts. The animals have only moderate cardiac hypertrophy and live a normal life span with no overt signs of degenerative vascular disease. Examination of arterial mechanical properties showed that the inner diameters of Eln(+/-) arteries were generally smaller than wild-type arteries at any given intravascular pressure. Because the Eln(+/-) mouse is hypertensive, however, the effective arterial working diameter is comparable to that of the normotensive wild-type animal. Physiological studies indicate a role for the renin-angiotensin system in maintaining the hypertensive state. The association of hypertension with elastin haploinsufficiency in humans and mice strongly suggests that elastin and other proteins of the elastic Fiber should be considered as causal genes for essential hypertension.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available